Ayumi Yoshifuji, Masataro Toda, Emi Oyama, Tetsuo Nakayama, Setsuko Mise-Omata, Kan Kikuchi, Mamoru Yoshizawa, Naohiko Kato, Haruki Wakai, Kiyoto Koibuchi, Kohkichi Morimoto, Yoshifumi Uwamino, Ho Namkoong, Ayako Shibata, Kaoru Wakabayashi, Motoko Fujino, Motoaki Komatsu, Naoki Mochizuki, Norihiko Kondo, Akihiko Yoshimura, Naoki Hasegawa, Munekazu Ryuzaki
BACKGROUND: Dialysis patients are susceptible to developing severe coronavirus disease 2019 (COVID-19) due to hypoimmunity. Antibody titers against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) after the primary vaccinations are lower in hemodialysis (HD) patients than in healthy individuals. This study aimed to evaluate the effect of a SARS-CoV-2 booster vaccination in HD and peritoneal dialysis (PD) patients based on antibody titers and cellular and humoral immunity. METHODS: Participants of the control, HD, and PD groups were recruited from 12 facilities...
March 8, 2024: Clinical and Experimental Nephrology